Fibrotic disease and the TH1/TH2 paradigm
Open accessThe DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, interferon-γ (IFNγ), produced by many immune cells including NK, NKT and T cells, has direct anti-fibrogenic activity on HSCs (70–72).”
From Hepatic Stellate Cell-Immune Interactions in NASH (2022) · cites this paper as [71]
Experimental — accuracy not yet measuredIn the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Recent evidence indicates that myofibroblast-induced fibrosis can be over-activated, not only in the setting of signaling through TGF-β, but also in the setting of Th2-derived cytokines IL-4 and IL-13; Th1 cytokines, such as IFN-γ, attenuate excessive scar formation [100, 101].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
In the citing paper
“Normally, myofibroblasts carefully coordinate the breakdown of granulation tissue and replacement with long-lasting type I collagen [100].”
From Immunology of Wound Healing (2018) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737 · cited 1×
“However, it is now described as a general immunosuppressive cytokine that downregulates chronic inflammatory responses through many mechanism”
BackgroundAlternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-3-460_4 · Cited by 4,529
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450
Interleukin-13: Central Mediator of Allergic Asthma
Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T. Y., Karp, C. L., & Donaldson, D. D. (1998) · Science · doi:10.1126/science.282.5397.2258 · Cited by 2,617
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
Grünig, G., Warnock, M., Wakil, A. E., Venkayya, R., Brombacher, F., Rennick, D. M., Sheppard, D., Mohrs, M., Donaldson, D. D., Locksley, R. M., et al. (1998) · Science · doi:10.1126/science.282.5397.2261 · Cited by 1,849
Zhu, Z., Homer, R. J., Wang, Z., Chen, Q., Geba, G. P., Wang, J., Zhang, Y., & Elias, J. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5909 · Cited by 1,719
Cited by
Items 201–300 of 1,000
Cellular and Humoral Autoreactivity in Idiopathic Pulmonary Fibrosis
Feghali-Bostwick, C. A., Tsai, C. G., Valentine, V. G., Kantrow, S., Stoner, M. W., Pilewski, J. M., Gadgil, A., George, M. P., Gibson, K. F., Choi, A. M. K., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2592 · Cited by 160
“The increased production of IL-10 by IPF CD4 T cells seen here is consistent with observations of TH2 dominance in many fibroproliferative disorders (4), although the actions of this particular cytokine have been variously implicated as both fibrosis promoting and inhibiting (4, 22).”
BackgroundInfluentialGraft versus Host Disease in the Bone Marrow, Liver and Thymus Humanized Mouse Model
Greenblatt, M. B., Vbranac, V., Tivey, T., Tsang, K., Tager, A. M., & Aliprantis, A. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044664 · Cited by 159
Therapeutic strategies for preventing skeletal muscle fibrosis after injury
Garg, K., Corona, B. T., & Walters, T. J. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00087 · Cited by 158
The molecular basis of hypertrophic scars
Zhu, Z., Ding, J., & Tredget, E. E. (2016) · Burns & Trauma · doi:10.1186/s41038-015-0026-4 · Cited by 156
Yang, H.-Z., Wang, J.-P., Mi, S., Liu, H.-Z., Cui, B., Yan, H.-M., Yan, J., Li, Z., Liu, H., Hua, F., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.09.019 · Cited by 155
Animal models of systemic sclerosis: Prospects and limitations
Beyer, C., Schett, G. A., Distler, O., & Distler, J. H. W. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27647 · Cited by 187
Mechanisms of Oncostatin M-Induced Pulmonary Inflammation and Fibrosis
Mozaffarian, A., Brewer, A. W., Trueblood, E. S., Luzina, I. G., Todd, N. W., Atamas, S. P., & Arnett, H. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7243 · Cited by 153
Reversible differentiation of myofibroblasts by MyoD
Hecker, L., Jagirdar, R., Jin, T., & Thannickal, V. J. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.03.016 · Cited by 153
Deciphering mechanisms of staphylococcal biofilm evasion of host immunity
Hanke, M. L., & Kielian, T. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00062 · Cited by 180
Bhattacharya, M., & Ramachandran, P. (2023) · Nature Immunology · doi:10.1038/s41590-023-01551-9 · Cited by 148
Targeting Fibrosis in Duchenne Muscular Dystrophy
Zhou, L., & Lu, H. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181e9a34b · Cited by 149
Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction
Tapmeier, T. T., Fearn, A., Brown, K., Chowdhury, P., Sacks, S. H., Sheerin, N., & Wong, W. (2010) · Kidney International · doi:10.1038/ki.2010.177 · Cited by 149
Interleukin‐13–producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis
Fuschiotti, P., Larregina, A. T., Ho, J., Feghali‐Bostwick, C., & Medsger, T. A. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37706 · Cited by 147
Fibrosis and immune dysregulation in systemic sclerosis
Chizzolini, C., Brembilla, N. C., Montanari, E., & Truchetet, M. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.09.016 · Cited by 165
“evidence indicates that indeed type 2 polarized responses are important for fibrosis development [42,43].”
BackgroundInhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
MacKinnon, A. C., Liu, X., Hadoke, P. W. F., Miller, M. R., Newby, D. E., & Sethi, T. (2013) · Glycobiology · doi:10.1093/glycob/cwt006 · Cited by 148
“…to arginase-1 could be considered profibrotic (Hesse et al. 2001) as arginase-1 up-regulates several genes involved in fibrosis (Liu et al. 2004; Wynn 2004; Fichtner-Feigl et al. 2006) such as fibronectin and other matrix proteins (Doucet et al. 1998; Rishikof et al. 2002; Herbert et al. 2004)…”
BackgroundMapping immune response profiles: The emerging scenario from helminth immunology
Díaz, A., & Allen, J. E. (2007) · European Journal of Immunology · doi:10.1002/eji.200737765 · Cited by 145
Chiu, H., Chen, C., Wu, M., Cheng, Y. ‐., & Tsai, T. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12461 · Cited by 144
Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice
Li, C. R., Lu, Y., Du, S., Li, S., Zhang, Y., Liu, F., Chen, Y., Weng, D., & Chen, J. (2017) · Theranostics · doi:10.7150/thno.20270 · Cited by 147
Pomeshchik, Y., Kidin, I., Korhonen, P., Savchenko, E., Jaronen, M., Lehtonen, Š., Wojciechowski, S., Kanninen, K. M., Koıstınaho, J., & Malm, T. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.002 · Cited by 151
“Chronic T cell activation can induce pathological fibrosis and scarring (Wynn, 2004).”
BackgroundPulmonary Fibrosis in Sarcoidosis. Clinical Features and Outcomes
Patterson, K. C., & Strek, M. E. (2013) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201303-069fr · Cited by 155
Theoret, C. L. (2016) · Wiley eBooks · doi:10.1002/9781118999219.ch1 · Cited by 147
Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis
Kokubo, K., Onodera, A., Kiuchi, M., Tsuji, K., Hirahara, K., & Nakayama, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.945063 · Cited by 167
Mylonas, K. J., Nair, M. G., Prieto-Lafuente, L., Paape, D., & Allen, J. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803463 · Cited by 140
Feng, W., Li, W., Liu, W., Wang, F., Li, Y., & Yan, W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2009.06.001 · Cited by 139
Potential roles of interleukin‐17A in the development of skin fibrosis in mice
Okamoto, Y., Hasegawa, M., Matsushita, T., Hamaguchi, Y., Huu, D. L., Iwakura, Y., Fujimoto, M., & Takehara, K. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34643 · Cited by 152
Murine Models of Chronic Graft-versus-Host Disease: Insights and Unresolved Issues
Chu, Y., & Gress, R. E. (2008) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2007.12.002 · Cited by 138
Morbidity in schistosomiasis: an update
Vennervald, B. J., & Dunne, D. W. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200410000-00009 · Cited by 137
An innately interesting decade of research in immunology
Germain, R. N. (2004) · Nature Medicine · doi:10.1038/nm1159 · Cited by 157
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice
Sahin, H., Borkham-Kamphorst, E., Kuppe, C., Zaldivar, M. M., Grouls, C., Al-samman, M., Nellen, A., Schmitz, P., Heinrichs, D., Berres, M.-L., et al. (2012) · Hepatology · doi:10.1002/hep.25545 · Cited by 135
Chegini, N. (2010) · Seminars in Reproductive Medicine · doi:10.1055/s-0030-1251476 · Cited by 152
Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis _ state of the art
Chen, C. Z., & Raghunath, M. (2009) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-2-7 · Cited by 148
Lymphatic Dysfunction, Leukotrienes, and Lymphedema
Jiang, X., Nicolls, M. R., Tian, W., & Rockson, S. G. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034008 · Cited by 144
“A Th1/Th2 paradigm in tissue fibrosis has been established (137).”
Fibrocytes, Wound Healing, and Corneal Fibrosis
de Oliveira, R. C., & Wilson, S. E. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.2.28 · Cited by 147
Furukawa, S., Moriyama, M., Tanaka, A., Maehara, T., Tsuboi, H., Iizuka, M., Hayashida, J., Ohta, M., Saeki, T., Notohara, K., et al. (2014) · Clinical Immunology · doi:10.1016/j.clim.2014.10.008 · Cited by 147
Novel Effector Molecules in Type 2 Inflammation: Lessons Drawn from Helminth Infection and Allergy
Nair, M. G., Guild, K. J., & Artis, D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1393 · Cited by 130
Xu, Q., Norman, J. T., Shrivastav, S., Lucio-Cazana, J., & Kopp, J. B. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00379.2006 · Cited by 130
The molecular mechanism of hypertrophic scar
Zhu, Z., Ding, J., Shankowsky, H. A., & Tredget, E. E. (2013) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-013-0195-5 · Cited by 128
Weng, H.-L., Liu, Y., Chen, J.-L., Huang, T., Xu, L.-J., Godoy, P., Hu, J.-H., Zhou, C., Stickel, F., Marx, A., et al. (2009) · Hepatology · doi:10.1002/hep.22934 · Cited by 129
Mechanisms for the Resolution of Organ Fibrosis
Horowitz, J. C., & Thannickal, V. J. (2018) · Physiology · doi:10.1152/physiol.00033.2018 · Cited by 144
Resolving an inflammatory concept: The importance of inflammation and resolution in tendinopathy
Dakin, S. G., Dudhia, J., & Smith, R. K. W. (2014) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2014.01.007 · Cited by 133
Sending a message: extracellular vesicles of pathogenic protozoan parasites
Szempruch, A. J., Dennison, L., Kieft, R., Harrington, J. M., & Hajduk, S. L. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.110 · Cited by 148
Mechanical force prolongs acute inflammation via T‐cell‐dependent pathways during scar formation
Wong, V. W., Paterno, J., Sorkin, M., Glotzbach, J. P., Levi, K., Januszyk, M., Rustad, K. C., Longaker, M. T., & Gurtner, G. C. (2011) · The FASEB Journal · doi:10.1096/fj.10-178087 · Cited by 126
Guillot, A., Hamdaoui, N., Bizy, A., Zoltani, K., Souktani, R., Zafrani, E.-S., Mallat, A., Lotersztajn, S., & Lafdil, F. (2014) · Hepatology · doi:10.1002/hep.26598 · Cited by 127
Molecular imaging of fibrosis: recent advances and future directions
Montesi, S. B., Désogère, P., Fuchs, B. C., & Caravan, P. (2019) · Journal of Clinical Investigation · doi:10.1172/jci122132 · Cited by 127
“Sanyal AJ, Friedman SL, McCullough AJ, Dimick-Santos L, American Association for the Study of Liver Diseases, United States Food Drug Administration.”
BackgroundNovel concepts in radiation-induced cardiovascular disease
Cuomo, J. R., Sharma, G. K., Conger, P. D., & Weintraub, N. L. (2016) · World Journal of Cardiology · doi:10.4330/wjc.v8.i9.504 · Cited by 133
Rockson, S. G. (2021) · Circulation Research · doi:10.1161/circresaha.121.318307 · Cited by 152
Cudejko, C., Wouters, K., Fuentes, L., Hannou, S. A., Paquet, C., Bantubungi, K., Bouchaert, E., Vanhoutte, J., Fleury, S., Remy, P., et al. (2011) · Blood · doi:10.1182/blood-2010-10-313106 · Cited by 125
The Multifaceted Aspects of Interstitial Lung Disease in Rheumatoid Arthritis
Cavagna, L., Monti, S. M., Grosso, V., Boffini, N., Scorletti, E., Crepaldi, G., & Caporali, R. F. (2013) · BioMed Research International · doi:10.1155/2013/759760 · Cited by 138
Complement C5 Mediates Experimental Tubulointerstitial Fibrosis
Boor, P., Konieczny, A., Villa, L., Schult, A. L., Diaeresis]cher, E. B., Rong, S., Kunter, U., van Roeyen, C. R. C., Polakowski, T., Hawlisch, H., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121343 · Cited by 124
Rickard, A. J., Morgan, J., Bienvenu, L. A., Fletcher, E. K., Cranston, G. A., Shen, J., Reichelt, M. E., Delbridge, L. M. D., & Young, M. J. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.203158 · Cited by 123
Targeted Deletion of CCR2 Impairs Deep Vein Thombosis Resolution in a Mouse Model
Henke, P. K., Pearce, C. G., Moaveni, D. M., Moore, A. J., Lynch, E. M., Longo, C. R., Varma, M. R., Dewyer, N. A., Deatrick, K. B., Upchurch, G. R., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3388 · Cited by 125
“Thrombus IL-2 was significantly reduced at 2 days in CCR2 / as compared with WT controls and was not detectable at other time points in either group (Fig.”
BackgroundResultInfluentialFuschiotti, P., Medsger, T. A., & Morel, P. A. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24432 · Cited by 138
Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis
Hu, V. H., Holland, M. J., & Burton, M. J. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002020 · Cited by 131
Chen, C., Wang, D., Moshaverinia, A., Liu, D., Kou, X., Yu, W., Yang, R., Sun, L., & Shi, S. (2017) · Cell Research · doi:10.1038/cr.2017.11 · Cited by 125
Redente, E. F., Higgins, D. M., Dwyer-Nield, L. D., Orme, I. M., Gonzalez-Juarrero, M., & Malkinson, A. M. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0609378 · Cited by 123
Rogers, M. E., Kropf, P., Choi, B., Dillon, R. J., Podinovskaia, M., Bates, P. A., & Müller, I. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000555 · Cited by 154
Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice
Alsamman, S., Christenson, S. A., Yu, A., Ayad, N. M. E., Mooring, M. S., Segal, J. M., Hu, J. K.-H., Schaub, J. R., Ho, S. S., Rao, V., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8798 · Cited by 122
“Tissue fibrosis is associated with high morbidity and mortality: Severe fibrosis is estimated to account for almost half of all deaths in the developed world (1).”
BackgroundExploration of radiation-induced lung injury, from mechanism to treatment: a narrative review
Yan, Y., Fu, J., Kowalchuk, R. O., Wright, C. M., Zhang, R., Li, X., & Xu, Y. (2022) · Translational Lung Cancer Research · doi:10.21037/tlcr-22-108 · Cited by 135
Aliprantis, A. O., Wang, J., Fathman, J. W., Lemaire, R., Dorfman, D. M., Lafyatis, R., & Glimcher, L. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700021104 · Cited by 122
Insights into the Pathophysiology of Hypertrophic Scars and Keloids: How Do They Differ?
Ghazawi, F. M., Zargham, R., Gilardino, M. S., Sasseville, D., & Jafarian, F. (2017) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000527576.27489.0f · Cited by 148
Patel, N., Kreider, T., Urban, J. F., & Gause, W. C. (2009) · International Journal for Parasitology · doi:10.1016/j.ijpara.2008.08.003 · Cited by 120
“Rapid induction of mechanisms of tissue healing and repair are required and, not surprisingly, recent studies have suggested that wound healing mechanisms are regulated by Th2-type immune responses (Gratchev et al., 2001; Wynn, 2004; Sakthianandeswaren et al., 2005).”
BackgroundSun, H. Q., Zhang, J., Zhang, H., Zou, Z., Wang, F. S., & Jia, J. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01561.x · Cited by 126
Evolutionary Roots of Arginase Expression and Regulation
Dzik, J. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00544 · Cited by 119
“Nonetheless, the importance of type 2 cytokines in damage tissue remodeling and fibrosis is well documented (70).”
BackgroundImmune Mechanisms of Pulmonary Fibrosis with Bleomycin
Ishida, Y., Kuninaka, Y., Mukaida, N., & Kondo, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043149 · Cited by 136
Manetti, M., Ibba‐Manneschi, L., Liakouli, V., Guiducci, S., Milia, A. F., Benelli, G., Marrelli, A., Conforti, M. L., Romano, E., Giacomelli, R., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119321 · Cited by 128
The economy of inflammation: when is less more?
Sears, B. F., Rohr, J. R., Allen, J. E., & Martin, L. B. (2011) · Trends in Parasitology · doi:10.1016/j.pt.2011.05.004 · Cited by 125
Lurje, I., Hammerich, L., & Tacke, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197378 · Cited by 126
Regulation of Immune Function by the Lymphatic System in Lymphedema
Kataru, R. P., Baik, J. E., Park, H. J., Wiser, I., Rehal, S., Shin, J. Y., & Mehrara, B. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00470 · Cited by 122
Tao, B., Jin, W., Xu, J., Liang, Z., Yao, J., Zhang, Y., Wang, K., Cheng, H., Zhang, X. Z., & Ke, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303463 · Cited by 126
Taylor, M. D., Harris, A., Nair, M. G., Maizels, R. M., & Allen, J. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6918 · Cited by 115
“Alternatively activated macrophages play an important role in controlling pathology during infection with Schistosoma mansoni (56), and are associated with tissue repair indicating a role in wound healing (39, 57).”
BackgroundSeki, A., Sakai, Y., Komura, T., Nasti, A., Yoshida, K., Higashimoto, M., Honda, M., Usui, S., Takamura, M., Takamura, T., et al. (2013) · Hepatology · doi:10.1002/hep.26470 · Cited by 114
Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis
Bellón, T., Martínez, V., Lucendo, B., del Peso, G., Castro, M. J., Aroeira, L. S., Rodríguez-Sanz, A., Ossorio, M., Sánchez-Villanueva, R., Selgas, R., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq771 · Cited by 114
Mina, an Il4 repressor, controls T helper type 2 bias
Okamoto, M., Van Stry, M., Chung, L., Koyanagi, M., Sun, X., Suzuki, Y., Ohara, O., Kitamura, H., Hijikata, A., Kubo, M., et al. (2009) · Nature Immunology · doi:10.1038/ni.1747 · Cited by 114
Mesenchymal stem cells in fibrotic diseases—the two sides of the same coin
Qin, L., Liu, N., Bao, C.-L.-M., Yang, D.-Z., Ma, G.-X., Yi, W.-H., Xiao, G.-Z., & Cao, H.-L. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-022-00952-0 · Cited by 114
Myofibroblasts and lung fibrosis induced by carbon nanotube exposure
Dong, J., & Ma, Q. (2016) · Particle and Fibre Toxicology · doi:10.1186/s12989-016-0172-2 · Cited by 119
Venkataraman, T., Coleman, C. M., & Frieman, M. B. (2017) · Journal of Virology · doi:10.1128/jvi.00182-17 · Cited by 111
Yu, J., Wang, M., Tai, H., & Cheng, N. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.07.022 · Cited by 117
The Dynamic Inflammatory Tissue Microenvironment: Signality and Disease Therapy by Biomaterials
Mata, R., Yao, Y., Cao, W., Ding, J., Zhou, T., Zhai, Z., & Gao, C. (2021) · Research · doi:10.34133/2021/4189516 · Cited by 131
“However, fibrosis can also be independent of TGF-β [156], wherein type 2 cytokine, namely IL-13, performs a major role in many cases [157].”
BackgroundInfluentialJAK3/STAT6 Stimulates Bone Marrow–Derived Fibroblast Activation in Renal Fibrosis
Yan, J., Zhang, Z., Yang, J., Mitch, W. E., & Wang, Y. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014070717 · Cited by 112
Vannella, K. M., Barron, L., Borthwick, L. A., Kindrachuk, K. N., Narasimhan, P. B., Hart, K. M., Thompson, R. W., White, S., Cheever, A. W., Ramalingam, T. R., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004372 · Cited by 111
Self-citationRadiation-Induced Lung Fibrosis: Preclinical Animal Models and Therapeutic Strategies
Jin, H. K., Yoo, Y., Kim, Y.-H., Kim, Y., Cho, J., & Lee, Y. (2020) · Cancers · doi:10.3390/cancers12061561 · Cited by 127
“IL-13 7 T cells (Thy-2 CD34+) − Important pro-fibrotic cytokines and closely related with fibrosis of lung [65,66]”
BackgroundLiu, Y., Meyer, C., Müller, A., Herweck, F., Li, Q., Müllenbach, R., Mertens, P. R., Dooley, S., & Weng, H.-L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003260 · Cited by 111
T follicular helper–like cells contribute to skin fibrosis
Taylor, D. K., Mittereder, N., Kuta, E. G., Delaney, T. A., Burwell, T. J., Dacosta, K., Zhao, W., Cheng, L., Brown, C., Boutrin, A., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5307 · Cited by 123
“Studies conducted in animal models and advances in the understanding of the progression of SSc in patients have led to the recognition that T helper (TH) cells are involved in both the early inflammatory and late fibrotic phases through interaction with differentiated fibroblasts (3, 4).”
BackgroundRegulatory T Cells in Systemic Sclerosis
Frantz, C., Auffray, C., Avouac, J., & Allanore, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02356 · Cited by 120
KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts
Ohshimo, S., Yokoyama, A., Hattori, N., Ishikawa, N., Hirasawa, Y., & Kohno, N. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.144 · Cited by 118
What is the best way to measure renal fibrosis?: A pathologist’s perspective
Farris, A. B., & Alpers, C. E. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.3 · Cited by 109
Luo, X., Ding, L. J., Xu, J., & Chegini, N. (2004) · Endocrinology · doi:10.1210/en.2004-1377 · Cited by 122
The Spectrum of Scarring in Craniofacial Wound Repair
desJardins-Park, H. E., Mascharak, S., Chinta, M. S., Wan, D. C., & Longaker, M. T. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00322 · Cited by 119
“The impact of fibrosis can hardly be understated; it is estimated that 45% of all deaths in the United States are attributable to fibrosis (Wynn, 2004).”
BackgroundWound dressings as growth factor delivery platforms for chronic wound healing
Catanzano, O., Quaglia, F., & Boateng, J. S. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1867096 · Cited by 115
Functional role of chemokines in liver disease models
Sahin, H., Trautwein, C., & Wasmuth, H. E. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.168 · Cited by 107
Cellular and molecular mechanisms in fibrosis
Dees, C., Chakraborty, D., & Distler, J. H. W. (2020) · Experimental Dermatology · doi:10.1111/exd.14193 · Cited by 121
Role of Oxidative Stress in Liver Disorders
Conde de la Rosa, L., Goicoechea, L., Torres, S., Garcia-Ruiz, C., & Fernandez-Checa, J. C. (2022) · Livers · doi:10.3390/livers2040023 · Cited by 107
Carulli, M. T., Ong, V. H., Ponticos, M., Shiwen, X., Abraham, D., Black, C. M., & Denton, C. P. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21396 · Cited by 110
The role of interleukin 17 in Crohn’s disease-associated intestinal fibrosis
Biancheri, P., Pender, S. L. F., Ammoscato, F., Giuffrida, P., Sampietro, G. M., Ardizzone, S., Ghanbari, A., Curciarello, R., Pasini, A., Monteleone, G., et al. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-13 · Cited by 110
Holden, J. A., Attard, T. J., Laughton, K. M., Mansell, A. S., O’brien-simpson, N. M., & Reynolds, E. C. (2014) · Infection and Immunity · doi:10.1128/iai.02325-14 · Cited by 127
The Cellular and Molecular Mechanism of Radiation-Induced Lung Injury
Huang, Y., Zhang, W., Yu, F., & Gao, F. (2017) · Medical Science Monitor · doi:10.12659/msm.902353 · Cited by 115
Fibrostenotic strictures in Crohn’s disease
Yoo, J. H., Holubar, S. D., & Rieder, F. (2020) · Intestinal Research · doi:10.5217/ir.2019.09148 · Cited by 118
“The MMP9 activates the latent TGF-β1 by cleaving the latency-associated peptide (LAP).(42) TGF-β1 is considered a major cytokine in intestinal fibrosis.”
BackgroundSahin, H., & Wasmuth, H. E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.004 · Cited by 114
Hepatic fibrosis 2006: Report of the third AASLD Single Topic Conference
Friedman, S. L., Rockey, D. C., & Bissell, M. D. (2007) · Hepatology · doi:10.1002/hep.21459 · Cited by 106
Chizzolini, C. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32830c45ae · Cited by 114
Metadata
- Authors
- Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Wynn, Thomas A.
- Venue
- Nature Reviews Immunology
- Published
- 2004-08
- Volume
- 4
- Issue
- 8
- Pages
- 583-594
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2702150
- OpenAlex
- W1983357763
- Cited by
- 1,765
- References
- 135
- Citations by year
- 2026: 46 · 2025: 76 · 2024: 93 · 2023: 104 · 2022: 126 · 2021: 96 · 2020: 99 · 2019: 83 · 2018: 91 · 2017: 95 · 2016: 87 · 2015: 91 · 2014: 94 · 2013: 82 · 2012: 75
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI001019, Z01AI000829)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- fibrosis, fibrogenesis, Th1/Th2 paradigm, T helper cells, idiopathic pulmonary fibrosis, liver fibrosis, systemic sclerosis, wound healing, fibroproliferative disorders
- MeSH terms
- Animals, Fibroblasts, Fibrosis, Humans, Macrophages, Transforming Growth Factor beta, Th1 Cells, Th2 Cells, Interleukin-13, Chemokines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.